CCL4 and hepatocellular carcinoma: HCC mouse model was then established using diethylnitrosamine (DEN)/CCl4 consisting of the injection of 25 mg/kg of DEN, followed by intraperitoneal injection of CCL4 for 12 weeks as a tumor promoter, and the tumor burden was analyzed after 12 weeks (Figure 1A).